The key facts

  • The Health Ministry has prepared a draft Cabinet of Ministers resolution on contracts for medicine procurement lasting up to three years
  • Implementation is planned in state procurement starting January 2027; the minister asked deputies to allocate sufficient funding in the 2027 budget
  • The conditional agreements mechanism has already been enshrined in law since March 1, 2025, but resolution No. 276 of 2022 prohibits it for budget-funded customers

What happened

On November 11, at a 'Government Hour' session in the Legislative Chamber of the Oliy Majlis, Health Minister Eldor Adilov said the ministry is preparing a transition to long-term contracts in state procurement of medicines. The occasion was a question from Ecological Party deputy Gulchehra Tajibayeva, who drew attention to problems with the regular supply of medicines and medical devices to patients: according to her, parliamentarians raise the issue of the absence of multi-year supply contracts every year. 'Since the budget is approved for one year, contracts are also concluded for one year. This, of course, creates numerous problems in the timely and regular supply of patients with medicines and necessary medical devices,' Gazeta quoted the deputy as saying.

The ministry's proposal

Adilov acknowledged that uninterrupted supply of medicines to the population remains one of the most pressing problems of the healthcare system: measures have been taken for several years, but technical and other difficulties arise in practice, and there are gaps in legislation. According to his explanation, the current practice is linked to the fact that the budget is adopted for one fiscal year, so both procurement financing and contracts were only possible for one year. Since June, the ministry, together with interested agencies, has been working on changing the procurement procedure — discussions took place in June, July and August, and the minister personally participated in a number of meetings. The result is a prepared draft Cabinet of Ministers resolution introducing the concept of a 'conditional agreement': contracts for medicine procurement lasting up to three years. According to the minister, such a mechanism is widely used in other countries and will create a basis for purchasing medicines at more favorable prices and delivering them uninterruptedly to patients through medical institutions. The new system is planned to be implemented in the state procurement process that starts in January 2027; the details of its application are to be set out in the draft.

Request for funding

Concluding his speech, Adilov asked deputies to take healthcare needs into account when considering the 2027 budget. He said the ministry has prepared calculations of the funds needed to supply patients with medicines and that the draft budget will soon be submitted to parliament. At the same time, the minister emphasized that changing the procurement mechanism without sufficient budget funding will not solve the problem — 'if there is no appropriate financial backing behind it, it will, of course, be difficult for us to supply medical institutions with medicines.' He did not disclose the specific amount the agency proposes to allocate in the 2027 budget for medicine procurement.

What is already enshrined in legislation

As Gazeta found out, the mechanism of conditional agreements lasting up to three years is already provided for in Uzbek legislation. By Law ORK-1005 of November 27, 2024, Article 38-2 'Conditional Agreement' was added to the law 'On State Procurement' (in force from March 1, 2025): under its provisions, a state customer may conclude with several suppliers selected through a selection process or tender agreements lasting from one to three years, indicating the approximate volume of goods; the customer is not obliged to purchase the entire stipulated volume. However, the regulation on state procurement approved by Cabinet of Ministers resolution No. 276 of May 20, 2022 contains a significant restriction: paragraph 168 directly prohibits budget-funded customers from conducting procurement through conditional agreements — this mechanism is oriented toward corporate customers. Thus, the mechanism itself is enshrined in law, but its use by budget-funded organizations is restricted by a subordinate act, and the draft resolution is intended to remove this obstacle for medicine procurement. Earlier, in November 2024, presidential resolution PQ-408 already provided for the possibility of centralized procurement of medicines, medical devices and medical equipment under contracts longer than one year directly from manufacturers or official distributors: for this purpose, it was planned to create a Procurement Center under the Health Ministry with 13 regional branches, and to calculate the need for medicines over a 15-month period.